MedTrace Logo

Nasal High Flow Therapy in Surgical Patients with Unrecognized Obstructive Sleep Apnea

NCT03964376 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2025-01-13

No results posted yet for this study

Summary

In this study the investigators will determine whether using high flow oxygen in moderate-to-severe Obstructive Sleep Apnea patients following a major non cardiac surgery is more efficacious than usual care in preventing decrease in oxygen level in blood.

Conditions

Interventions

OTHER

Nasal High Flow

Delivery of oxygen via OptiflowTM system (AirvoTM, Fisher \& Paykel Inc.) with airflow of 20 to 50 Litre/minute

OTHER

Usual Care

Delivery of oxygen at 2-4 Litre/minute via nasal cannula or 6 Litre/minute via face mask

Sponsors & Collaborators

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Frances Chung, MBBS FRCPC · University of Toronto/ University Health Network

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2025-01-08
Completion
2025-01-08

Countries

  • Canada
  • Hong Kong
  • Malaysia
  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03964376 on ClinicalTrials.gov